Back to Agenda
Session 22: Interactions with FDA - Part 2
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- Principles for Communicating with FDA
- Meeting Etiquette
- Resolving Issues or Disputes with FDA
- Summary on Interacting with FDA
- Advisory Committee Meetings
- Advisory Committee Meeting Video
Have an account?